AIM 8-K 2026-09-04

AIM ImmunoTech Inc. (AIM) 8-K dated 2026-09-04 — accession 0001493152-26-041537.

AIM ImmunoTech Inc. (AIM) common stock.

AIM ImmunoTech Inc. filed a 8-K on 2026-09-04. Accession 0001493152-26-041537.

This 8-K covers: Material agreement (Item 1.01), Agreement ended (Item 1.02), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AIM revenue for 2025-12-31 was $88.0K. Net income was -$14.0M. Revenue was down 48.2% from 2024-12-31 to 2025-12-31. AIM currently screens at market cap $4.6M.

Not investment advice. The AIM SEC hub lists recent forms. The stock page is the research view.